Natalie C.
Ward
ab,
Jonathan M.
Hodgson
a,
Richard J.
Woodman
c,
Diane
Zimmermann
d,
Laure
Poquet
d,
Antoine
Leveques
d,
Lucas
Actis-Goretta
d,
Ian B.
Puddey
a and
Kevin D.
Croft
*a
aSchool of Medicine & Pharmacology, University of Western Australia, Perth, Australia. E-mail: kevin.croft@uwa.edu.au; Fax: +61 8 9224 0246; Tel: +61 8 9224 0275
bSchool of Biomedical Sciences & Curtin Health Innovation Research Institute, Curtin University, Perth, Australia
cSchool of Medicine, Flinders University, Adelaide, Australia
dNestle Research Centre, Lausanne, Switzerland
First published on 19th April 2016
Coffee is a rich source of polyphenols, primarily chlorogenic acids (CGA). Certain polyphenols and polyphenol-rich foods and beverages have been shown to improve endothelial function and lower blood pressure (BP). The aim of the present study was to investigate the acute effect of two doses of CGA (5-CGA) on endothelial function and BP. In a cross-over study, 16 healthy men and women received: (i) 0 mg purified 5-CGA (control group); (ii) 450 mg purified 5-CGA; (iii) 900 mg purified 5-CGA; and (iv) 200 mg purified (−)-epicatechin (positive control) in random order one week apart. Peak and continuous mean (60 to 240 s post ischaemia) flow-mediated dilation (FMD) was measured at baseline, 1 h and 4 h. BP was measured at baseline and every 30 min to 4 h. Plasma CGA and epicatechin levels were significantly increased at both 1 h and 4 h post their respective treatments. Peak FMD was not significantly altered by either dose of 5-CGA or the epicatechin, relative to control (p > 0.05). Relative to control, effects on continuous mean FMD response following 450 mg 5-CGA and 900 mg of 5-CGA (0.47 ± 0.16%, p = 0.016 and 0.65 ± 0.16%, p < 0.001, respectively) at 1 h and (0.18 ± 0.17%, p = 0.99 and 0.44 ± 0.16%, p < 0.05, respectively) at 4 h. There was no significant effect of any of the treatments on BP. In conclusion, the present study has found no significant effect of 5-CGA, at 450 and 900 mg, on peak FMD response. However, there were significant improvements in mean post-ischaemic FMD response, particularly at the 1 h time point in this group of healthy individuals.
Coffee is one of the most widely consumed beverages in the world and represents an important dietary source of polyphenolic compounds. The major polyphenolic compounds found in coffee are chlorogenic acids (CGA), which represents ∼86% of total polyphenol content. Coffee drinkers can have a daily intake of 0.5–1 g per day of CGA, while abstainers typically consume <100 mg per day.3 While the predominant isomer found in coffee is 5-CGA, the actual amount and composition of coffee polyphenols can be affected by brewing methods.4 Epidemiological studies, and meta-analysis derived from these studies, have suggested that moderate coffee consumption (3–4 cups per day) is associated with beneficial effects on a range of chronic diseases, including CVD and type 2 diabetes.5–7
Several other plant-based polyphenols have been shown to have beneficial effects on NO status and endothelial function. Loke et al. demonstrated that pure quercetin and epicatechin, polyphenols found in fruits, cocoa and tea, significantly increased NO status 2 h after ingestion.8 Schroeter et al. observed beneficial effects on endothelial function following ingestion of pure epicatechin.9 Studies looking specifically at CGA are limited. A recent acute study demonstrated a reduction in BP 1 h post ingestion of 400 mg of CGA (3-CQA, Sigma Aldrich). There were no significant effects on endothelial function or NO production.10
The timing of the measurements, along with the dose of polyphenols given are important considerations. Following ingestion of CGA, peak circulating concentrations of CGA are reached at approximately 1 hour, and CGA metabolites begin to appear in the circulation from approximately 3–4 hours.11 With this in mind, the aim of the present study was to investigate the effect of a 450 mg and a 900 mg dose 5-CGA on endothelial function and BP. The doses were chosen to represent the CGAs present in 4 and 8 cups (approx. 111 mg per cup) of coffee respectively.12 Endothelial function measurements were taken at baseline and 1 h and 4 h post-treatment to coincide with peak plasma concentrations.11 BP was measured at baseline and then every 30 min post-treatment. Participants were selected based on an impaired endothelial function (a screening peak flow-mediated dilatation (FMD) response between 3–8%), but were otherwise healthy. The primary outcome of this study was peak FMD response. The major secondary outcomes were the continuous mean FMD response between 60 to 240 s post-ischaemia, which represents a continuous vascular dilatory response to ischaemia, and clinic BP.
All participants were advised not to consume more than 2 pieces of fruit, red wine or dark chocolate in the 24 h period prior to their study visit. Tea and coffee consumption was not permitted 12 h prior to their study visit. On the morning of their study visit, all participants consumed a standardised breakfast (2 pieces of white bread with cheese, tub of plain yoghurt and water), approximately 2 h prior to their visit. Participants then underwent a baseline FMD assessment of their brachial artery, BP measurement and provided a blood sample. They were allocated to receive the study treatments in random order via computer generated block randomisation. Both the participants and the study personnel were blinded to the treatments for the duration of the study and subsequent analysis. Treatments were as follows; (i) 1 g maltodextrin (control group), (ii) 450 mg purified 5-CGA + 1 g maltodextrin, (iii) 900 mg purified 5-CGA + 1 g maltodextrin, or (iv) 200 mg purified (−)-epicatechin + 1 g maltodextrin (positive control). Treatments were given dissolved in 200 mL of warm water and consumed within 10 minutes, with a minimum one-week washout between visits. At 1 h and 4 h post-treatment, participants underwent another FMD assessment and provided a blood sample. BP was monitored every 30 min from baseline to 4 h. The study was approved by the University of Western Australia, Human Research Ethics Committee.
Analysis of scans was performed with semi-automated edge-detection software.14,15 This automatically calculated the brachial artery diameter, corresponding to the internal diameter. This was gated to the R wave of ECG, with measurements taken at end diastole. Analysis was performed by an experienced observer, blinded to the study treatments. Reproducibility studies have previously demonstrated an intra subject coefficient of variation of 14.7%.15 FMD response was assessed in two ways. Firstly, as a peak FMD response following ischaemia. Secondary analysis was carried out by measuring FMD response every 10 seconds from 60 s (average time to peak dilatation post-ischemia), to 4 min (240 s) post cuff deflation as a measure of continuous post-ischaemic FMD response. This outlined us the opportunity to detect smaller differences following the CGA treatments. The FMD response provides a guide to NO-mediated endothelial cell function.16
All participants (N = 16) | |
---|---|
Data are presented as mean (SD). | |
Age (years) | 59.9 (8.2) |
Gender | 6 men/10 women |
Caucasian | 16 |
Screening FMD (%) | 5.4 (1.2) |
Height (cm) | 168.4 (10.0) |
Weight (kg) | 70.5 (13.2) |
BMI (kg m−2) | 24.7 (3.3) |
Systolic BP (mmHg) | 115.1 (9.1) |
Diastolic BP (mmHg) | 67.8 (7.4) |
Heart rate (bpm) | 56.8 (7.4) |
Time | Estimated difference (95% CI) v control | ||||
---|---|---|---|---|---|
0 h | 1 h | 4 h | 1 h | 4 h | |
Results are presented as mean (SD).a Estimated differences at 1 hour and 4 hours were obtained from a mixed effects regression model (see statistical methods section for details). | |||||
Control (n = 14) | 6.7 (2.5) | 7.1 (3.0) | 7.6 (2.5) | ||
450 mg 5-CGA (n = 15) | 6.5 (2.1) | 7.1 (2.3) | 6.9 (3.1) | 0.78 (−0.96, 2.52) | −0.06 (−1.82, 1.71) |
900 mg 5-CGA (n = 14) | 6.1 (1.8) | 7.2 (2.9) | 7.2 (2.6) | 0.71 (−1.02, 2.43) | 0.22 (−1.55, 1.99) |
Epicatechin (n = 15) | 6.1 (1.2) | 6.8 (2.0) | 7.5 (2.8) |
BP (mmHg) | |||||||||
---|---|---|---|---|---|---|---|---|---|
0 h | 0.5 h | 1 h | 1.5 h | 2 h | 2.5 h | 3 h | 3.5 h | 4 h | |
Results are presented as mean systolic BP/mean diastolic BP (SD). | |||||||||
Control (n = 14) | 110/69 (7/7) | 113/65 (7/6) | 117/68 (14/9) | 116/79 (9/11) | 118/69 (11/8) | 121/69 (12/8) | 118/70 (14/8) | 118/70 (13/9) | 119/70 (8/7) |
450 mg 5-CGA (n = 15) | 109/65 (11/7) | 112/67 (9/8) | 115/67 (14/9) | 122/82 | 118/68 (12/9) | 117/70 (9/8) | 119/69 (11/8) | 118/69 (8/8) | 121/70 (11/8) |
900 mg 5-CGA (n = 14) | 110/64 (8/7) | 114/67 (7/8) | 113/67 (7/7) | 119/70 (9/7) | 120/71 (11/7) | 120/71 (11/7) | 118/70 (7/7) | 120/69 (9/10) | |
Epicatechin (n = 15) | 113/66 (12/9) | 112/67 (9/8) | 113/68 (9/9) | 117/71 (12/8) | 118/68 (11/9) | 120/70 (13/9) | 122/70 (14/10) | 122/71 (11/10) |
Nitrate (nM) | |||
---|---|---|---|
0 h | 1 h | 4 h | |
Results are presented as mean (SD). | |||
Control (n = 14) | 131 (98) | 237 (229) | 205 (97) |
450 mg 5-CGA (n = 15) | 123 (72) | 187 (73) | 218 (87) |
900 mg 5-CGA (n = 14) | 123 (62) | 195 (125) | 185 (106) |
Epicatechin (n = 15) | 164 (203) | 250 (258) | 165 (78) |
There is very little work investigating the direct effect of 5-CGA, the major coffee polyphenol, on vascular function. A recent study investigating the acute effect of 400 mg of 3-CGA in healthy subjects demonstrated a reduction in BP at 1 h post consumption. However, this was not associated with any improvement in peak FMD response or circulating nitroso/nitric oxide species.10 In the present study, we used a comparable dose of 5-CGA, as well as a higher dose, and measured BP every 30 minutes and FMD response at both 1 h and 4 h post-consumption. Although we did not observe any improvement in BP or peak FMD response, there was a significant dose-related effect on continuous post-ischaemic FMD response. Measurement of the continuous FMD dilatory response provides greater statistical power and allows us to observe smaller, yet still statistically significant, results. It may also be more physiologically relevant than measurement of a single time point peak response, representing a sustained improvement on vascular function.
The low dose used in the present study corresponds to the amount of CGA found in approximately 4 cups of regular roasted coffee (or 2 cups of a CGA-enriched coffee), while the high dose corresponds to approximately 8 cups of regular coffee (or 4 cups of a CGA-enriched coffee). However, the exact amount of CGA found in a regular cup of coffee can differ depending on both the type of coffee used and the brewing methods.18 Following ingestion, CGA undergoes extensive metabolic transformation in both the intestine and colon before absorption, as well as following absorption in the liver. As a result, it may be the metabolites of CGA (and other ingested polyphenols) that have significant biological activity and subsequent health benefits.2 Although the bioavailability of these metabolites has been studied, it is likely that this is also affected by biological and chemical differences, as well as individual differences in enzymatic modification, metabolite transport and gut microflora.2,4 Although participants were advised to reduce their polyphenolic intake prior to each study visit, we cannot rule out the influence of background diet on both the metabolism of these compounds and their subsequent in vivo effects. As a result, there may be significantly different responses and effects between individuals following both coffee consumption and ingestion of isolated pure polyphenolic compounds. The modest increase in continuous mean FMD response that we observed at 1 h may reflect peak plasma CGA or metabolite concentrations following transformation of the parent compound. This effect was diminished at 4 h post consumption at the low dose, suggesting the active metabolites were either excreted, or further metabolised into inactive compounds.
It is somewhat surprising that epicatechin, our positive control, had no effect on peak FMD response, particularly given several other studies have previously demonstrated a benefit.8,9 The dose used in the present study was similar to that used in previous studies, and while Loke et al. didn't measure FMD response directly, Schroeter et al. measured response at 2 h post-treatment, although it should be noted that this was only performed in 3 study participants. It may be that by measuring FMD response at 1 h and 4 h in the present study, we have missed the peak beneficial effect of this particular dietary polyphenol on endothelial function.
There are a number of limitations to consider when interpreting the results of the present study. Although the study was a randomised controlled cross-over study, the number of participants was small, with 14 completing all four treatment arms. This limited our power to detect a relatively small change in FMD response. Secondly, it might be that important time points have been missed in choosing when to measure FMD response. This is particularly noticeable when considering the lack of effect seen with epicatechin. The time points chosen for this study were based on peak times for CGA and its metabolites. Thirdly, although we recruited participants based a screening FMD response between 3–8%, they were considered to be otherwise healthy. This may mean that any observed benefit of the CGA compounds may have been too small to detect, as the participants weren't considered to be a high-risk group with endothelial dysfunction. Future studies in populations with existing CVD or pre-existing CVD risk factors may help to elucidate the beneficial effects of this compound on vascular function. Furthermore, the use of an isolated compound, specifically 5-CGA, may have also limited the interpretation of our findings. Although it is considered one of the major polyphenolic compounds in coffee, there are many other compounds present. Use of a single, purified compound in the present study may have meant that any additive or synergistic effects of other polyphenols also found in coffee (particularly after roasting), could not be observed.
In conclusion, there was no significant effect of 5-CGA or epicatechin on the peak FMD response, our primary outcome. We did observe a dose-related improvement in continuous mean FMD response for 5-CGA at 1 h post ingestion, which was diminished by 4 h. Future studies examining whole coffee, as well as high-risk population groups, are warranted.
This journal is © The Royal Society of Chemistry 2016 |